Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: A survey of 124 cases

Modern Pathology

Volumn 11, Issue 5, 1998, Pages 457-463

  Lai, R ^a   Medeiros, L J ^a   Coupland, R ^b   McCourty, A ^a   Brynes, R K ^a,c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cyclin D1; E2F 1; Immunohistochemistry; Ki 67; Mantle cell lymphoma

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DIFFERENTIAL DIAGNOSIS; GERMINAL CENTER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA;

CARRIER PROTEINS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOID TISSUE; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; REFERENCE VALUES; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0031966164     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Slansky JE, Farnham PJ. Introduction to the E2F family: protein structure and gene regulation. In: Farnham PJ, editor. Transcriptional control of cell growth: the E2F gene family. Current topics in microbiology and immunology. Berlin: Springer; 1996. p. 1-30.
2. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
3. Sellers WR, Kaelin WG. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 1997;15: 3301-12.
4. Helin K, Lees JA, Vidai M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992;70:337-50.
5. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchanbaum F, Fuchs T, et al. A cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992;70:351-64.
6. Shan B, Zhu X, Chen PL, Durfee T, Yang Y, Sharp D, et al. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 1992;12: 5620-31.
7. Nevins JR. A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-9.
8. Hunter T, Pines J. Cyclins and cancer: II. cyclin D and cdk inhibitors come of age. Cell 1994;79:573-82.
9. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the pRb protein. Cell 1991;65:1053-61.
10. Helin K, Wu CL, Fattaey AR. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993;13:6501-8.
11. Helin K, Harlow E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol 1993;3:43-6.
12. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. The interaction of the Rb with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1992;6:177-85.
13. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4. Genes Dev 1993;7:331-42.
14. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994;9:2663-74.
15. Krek W, Livingston DM, Shirodkar S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 1993;262: 1557-60.
16. Helin K, Wu C, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev 1993; 7:1850-61.
17. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcriptional factor E2F-1 induces quiescent cells to enter S phase. Nature 1993;365:349-52.
18. Adams PD, Kaelin WG. The cellular effects of E2F overexpression. In: Farnham PJ, editor. Transcriptional control of cell growth: the E2F gene family. In: Current topics in microbiology and immunology. Berlin: Springer; 1996. p. 79-93.
19. Qin XQ, Livingston DM, Kaelin WG, Adams PD. Deregulated E2F-1 transcription factor expression leads to S-phase and p53-mediated apoptosis. Proc Natl Acad Sci U S A 1994;91: 10918-22.
20. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E, et al. Amplification of the E2F-1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 1995;25:130-8.
21. Hall M, Peter G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv Cancer Res 1996;68:67-108.
22. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1(bcl-1) in mantle cell lymphoma: enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997;5:45-8.
23. Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997;89:272-80.
24. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996;87:4302-10.
25. Williams ME, Whitefield M, Swerdlow SH. Analysis of the cyclin-dependent kinase inhibitors, p18 and p19, in mantle-cell lymphoma and chronic lymphocytic leukemia. Annu Oncol 1997;8(Suppl 2):71-3.
26. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphoma: detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
27. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (bcl-1, PRAD-1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
28. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, et al. The nuclear staining pattern observed with monoclonal antibody against PRAD/cyclin D1 correlates with the mRNA overexpression in mantle cell lymphoma. Jpn J Cancer Res 1995;86:890-8.
29. Nakamura S, Yatabe Y, Kuroda H, Ueda R, Takahashi T, Sushi T, et al. Immunostaining of PRAD-1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. Leukemia 1997;11(Suppl 3):536-7.
30. Yatabe Y, Nakamura S, Seto M, Kuroda H, Kagami Y, Suzuki R, et al. Clinicopathologic study of PRAD-1/Cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma: a distinct molecular pathologic entity. Am J Surg Pathol 1996;20:1110-22.